𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationship of high-density lipoprotein subfractions and cholesteryl ester transfer protein in plasma to carotid artery wall thickness

✍ Scribed by B. Föger; G. Luef; A. Ritsch; C. Schmidauer; A. Doblinger; M. Lechleitner; F. Aichner; J. R. Patsch


Publisher
Springer
Year
1995
Tongue
English
Weight
410 KB
Volume
73
Category
Article
ISSN
0946-2716

No coin nor oath required. For personal study only.

✦ Synopsis


High plasma concentrations of high-density lipoprotein (HDL) cholesterol are a powerful indicator of low vascular risk. By decreasing HDL cholesterol, cholesteryl ester transfer protein (CETP) could perhaps constitute an atherogenic protein. We measured HDL cholesterol and HDL subfractions and quantified CETP mass in fasting plasma in 21 asymptomatic probands, and related these variables to the mean intima media thickness of the extracranial carotid arteries. HDL 2 cholesterol, the less dense HDL subfraction, was inversely related to carotid wall thickness (r=-0.378; P<0.05), and CETP was directly related to carotid wall thickness (r=0.436; P<0.05). In plasma CETP is associated mostly with the HDL 3 subfraction. We therefore calculated from our measurements the relative CETP content of HDL 3, i.e., CETP/HDL 3 cholesterol. This ratio was correlated with carotid wall thickness stronger than any other variable measured (r=0.718, P<0.001). We conclude that variation in HDL subfractions and CETP may be more closely associated with carotid intima media thickness than the accepted strong risk factor of HDL cholesterol.


📜 SIMILAR VOLUMES


Cholesteryl-ester transfer protein enhan
✍ David Hine; Bharti Mackness; Mike Mackness 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Therapeutic strategies to increase high-density lipoprotein (HDL) to treat or prevent vascular disease include the use of cholesteryl-ester transfer protein (CETP) inhibitors. Here, we show, to the best of our knowledge for the first time, that addition of CETP to HDL enhances the ability of HDL to

Decrease of hepatic triglyceride lipase
✍ Dr. Hisatoyo Hiraoka; Shizuya Yamashita; Yuji Matsuzawa; Masaharu Kubo; Shuichi 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 937 KB

Serum levels of high-density lipoprotein cholesterol are often increased in patients with primary biliary cirrhosis. To elucidate the mechanism of the elevation of high-density lipoprotein cholesterol levels in this disease, lipoprotein abnormalities were analyzed in 10 patients subdivided into two

Evaluation of G-to-A substitution in the
✍ Harukuni Akita; Hitoshi Chiba; Masahiro Tsuji; Shu-Ping Hui; Yukihiro Takahashi; 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 580 KB

The effect of a polymorphism, guanine (G) to adenine (A) substitution in the promoter of apolipoprotein A-I gene at a position 78 bp upstream of the transcription initiation site, on the serum high-density lipoprotein (HDL)-cholesterol level was studied in 168 Japanese subjects with HDL-cholesterol